Kortrijk Cancer Centre AZ Groeninge: Difference between revisions
| Line 328: | Line 328: | ||
</div> | </div> | ||
== [[ | == [[isEHDENParticipant::EHDEN_Participation_(Kortrijk_Cancer_Centre_AZ_Groeninge)|EHDEN Participation]] == | ||
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> | ||
Revision as of 12:13, 7 November 2023
Go back to Cancer Centers list.
Trials
Experts
Learning Resources
Trainings: Symposia and Training
Primary purpose: To offer symposia and training opportunities tailored to various healthcare professionals.
Target audience: Doctors, general practitioners, physiotherapists and related professionals.
Access Information: Information [1].
Events: Workshops and Events
Primary purpose: To offer workshops and information sessions designed to support and provide valuable resources for patients and relatives.
Target audience: Future parents, patients, their families and informal caregivers.
Access Information: Information [2].
Novel Therapies and Diagnostic Methods
Diagnostics
| Radiology | |||
|---|---|---|---|
| Type | Name | Availibility | Uses per year |
| Machine | CT scanners | yes | |
| Machine | MRI (specify the strength and field of the techniques) | yes (type not informed) | |
| Machine | Mammography (please specify analogic mammography or digital) | yes (type not informed) | |
| Machine | Digitalised imaging (PACS) | yes | |
| Machine | Ultrasound | yes | |
| Machine | Gamma Camera | yes | |
| Technique | X-rays | yes | |
| Nuclear Medicine | |||
| Type | Name | Availibility | Uses per year |
| Machine | Pet Scan | yes | |
| Machine | PET CT | yes | |
| Machine | PET/MRI | yes | |
| Machine | SPECT | yes | |
| Machine | SPECT CT | yes | |
| Technique | Sentinel node scintigraphy | yes | |
| Technique | Bone scintigraphy | yes | |
| Pathology | |||
| Type | Name | Availibility | Uses per year |
| Facility | Cytology laboratory | yes | |
| Facility | Histopathology laboratory | yes | |
| Technique | FISH (Fluorescence In Situ Hybridization) | yes | |
| Technique | PCR (Polymerase Chain Reaction) | yes | |
| Technique | Immunofluorescence techniques | yes | |
| Technique | Histochemistry | yes | |
| Technique | Techniques for molecular pathology | yes | |
| Pathology: Molecular Tests | |||
| Type | Name | Availibility | Uses per year |
| Technique | PDL1 | yes | |
| Technique | PI3KCA | yes | |
| Technique | ER | yes | |
| Technique | BRAF | yes | |
| Technique | RET | yes | |
| Technique | KRAS | yes | |
| Technique | EGFR | yes | |
| Technique | ALK | yes | |
| Technique | ROS | yes | |
| Technique | HER2 status | yes |
Treatment
| Surgical Oncology | |||
|---|---|---|---|
| Type | Name | Availibility | Uses per year |
| Specialist | Urological surgery | 1 | |
| Specialist | Thoracic surgery | 4 | |
| Specialist | Digestive surgery | 4 | |
| Specialist | Neurosurgery | 3 | |
| Specialist | Head and neck surgery | 3 | |
| Specialist | Oncoplastic surgery | 3 | |
| Technique | Robotic surgery | yes | |
| Technique | spinal decompression surgery for vertebral metastases | yes | |
| Radiotherapy | |||
| Type | Name | Availibility | Uses per year |
| Machine | Linear accelerators with IGRT | 3 | |
| Technique | Stereotactic intra- and extracranial radiotherapy | yes | |
| Technique | Intraoperative Radiotherapy (IORT) | yes | |
| Technique | Respiratory motion management | yes | |
| Technique | PET CT treatment planning | yes | |
| Hemato-Oncology / Bone Marrow Transplants | |||
| Type | Name | Availibility | Uses per year |
| Technique | Allogenic stem cell transplants | yes | |
| Technique | Autologous stem cell transplants | yes | |
| Specialists | |||
| Type | Name | Availibility | Uses per year |
| Specialist | Physician with a specialisation in palliative care | 2 | more than 600 palliative patients annually |
| Specialist | Medical oncologist | yes | |
| Specialist | Physician specialised in pain treatment | 7 | |
| Specialist | Neurologist | 1 | |
| Specialist | Lung physician | 8 | |
| Specialist | Radiotherapist | 6 | |
| Specialist | Psychologist or Psychotherapist | 10 | |
| Specialist | Psychiatrist | yes | |
| Specialist | Pharmacist | yes | |
| Specialist | Social worker | 30 | |
| Specialist | Spiritual care | 5 | |
| Specialist | Physiotherapist | yes | |
| Specialist | Dietitian | 5 | |
| Others | |||
| Technique | Hormonal therapy | yes | |
| Technique | D-J stent | yes |
Quality of Life
| Others | |||
|---|---|---|---|
| Type | Name | Availibility | Uses per year |
| Facility | Supportive care unit | yes | |
| Facility | Survivorship program | yes |
Patient Association: Patient Advisory Board Cancer Center Kortrijk (PARkk)
Primary purpose: It aims to guarantee an active representation of patients or patients' relatives in the cancer care organization.
Target audience: Patients in cancer treatment, their relatives, and representatives of the Kortrijk Cancer Center.
Access: Information [3].
Course: Creative Center Workshops
Content type: Provide art workshops as a leisure activity to share feelings and connect with others.
Target audience: Patients in cancer treatment, patients who finished cancer treatment, and their relatives.
Access: Information [4]
Resource: ASEM Meetings
Content type: It comprises meetings guided by themes that involve coping with feelings, creating connections, and creating a positive mentality.
Target audience: Patients with terminal cancer from the AZ Groeninge Hospital.
Access: Information [5].
Resource: Trials List
Primary Purpose: Provides a tool for patients to find active trials to participate in.
Target audience: Oncological patients.
Access: Information [6].
Service: Onco-Home
Content type: Provides specialized care at home by a trained nurse to prepare the patients for treatments in the day hospital and avoid the number of hospital visits.
Target audience: Oncological and haematological patients treated in AZ Groeninge, Sint-Jozefskliniek Izegem or OLV van Lourdes Hospital Waregem; and who preferably have a Port-a-Cath (implanted catheter).
Access: Information [7].
Service: Onco-Coach
Content type: Nurses promote closer contact between the hospital, the patients, and their relatives. These professionals help the patients deal with the disease and inform them about treatments.
Target audience: Patients in cancer treatment and their relatives.
Access: Information [8].
Service: Oncological Rehabilitation Program
Content type: It's a 12-week program that promotes physical rehabilitation and psycho-educational sessions.
Target audience: Patients who finished cancer treatment.
Access: Information [9].
Service: Strong
Content type: It is a 10-month program supplementary to the onco-rehabilitation in which patients can choose to enhance their physical performance in swimming, cycling, or running. The program promotes an individual online training program and group training. It includes a consultation with a doctor of physical medicine, biomechanical screening, and a fitness test.
Target audience: Patients who finished cancer treatment.
Access: Information [10].
Service: Stronger on the Road
Content type: It is a 12-week exercise program that includes a consultation with a doctor of physical medicine and a biomechanical screening before the physical guidance.
Target audience: Patients in cancer treatment.
Access: Information [11].
EHDEN Participation
The Kortrijk Cancer Centre AZ Groeninge is part of the EHDEN Network of Data Partners.
The European Health Data and Evidence Network (EHDEN) aims to standardize European health data using OMOP-CDM to facilitate research. The project creates a federated network of data sources for easy access by researchers and policymakers. Its goal is to improve healthcare outcomes through better data quality and interoperability.
Primary purpose: Provide a dataset for selected medical conditions extracted from the electronic patient record to be used in research.
Type of information: The AZ Groeninge database contains comprehensive patient data, including textual records processed by context-specific NLP algorithms, and maps up to 250 clinically relevant datapoints to OMOP-CDM for each clinical context.
Data level: Regional level.
Number of records: 679,000 patients.
Data range: 2010.
Open Data Access: Data is not publicly available. Instructions for data request [12].
Contact information: Contact [13].
